The 3P Study
Research type
Research Study
Full title
Point-of-Care-Devices as Predictors of DSPN
IRAS ID
314959
Contact name
Solomon Tesfaye
Contact email
Sponsor organisation
Sheffield Teaching Hospitals NHS Foundation Trust
Duration of Study in the UK
1 years, 0 months, 0 days
Research summary
The purpose of this study is to gather information about point-of-care devices that have been developed for diagnosing nerve damage, which some people develop as a result of having diabetes. Nerve damage in diabetes is often detected late when irreversible damage has already occurred. This can put people at risk of developing ulcers and infections in their feet. Such problems with the feet can lead to distress and significantly affect the quality of life of people with diabetes and cause enormous expense to the NHS.
The devices that will be tested in this study are called DPN-Check and SUDOSCAN. These point-of-care devices can be used at the time and place of patient care, such as during a clinic appointment or attendance to your GP, and provide an immediate result that does not rely on input from patients. Both tests take 2-3 minutes each to perform and have been proven to detect nerve damage in diabetes. However, it is not known whether these tests can predict nerve damage and other long term foot problems in people with diabetes in the future.
The aim of the study is to determine the ability of DPN-Check and/or SUDOSCAN to act as prognostic indicators of the future onset of nerve damage in people with diabetes.
REC name
North East - Newcastle & North Tyneside 1 Research Ethics Committee
REC reference
22/NE/0126
Date of REC Opinion
28 Jul 2022
REC opinion
Further Information Favourable Opinion